Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.530
-0.010 (-0.65%)
At close: Nov 4, 2024, 4:00 PM
1.520
-0.010 (-0.68%)
After-hours: Nov 4, 2024, 6:22 PM EST
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $66.21 million as of November 5, 2024. Its market cap has increased by 83.93% in one year.
Market Cap
66.21M
Enterprise Value
21.15M
1-Year Change
83.93%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.60M to $66.21M, a decrease of -92.26%. That is a compound annual growth rate of -37.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2024 | 66.20M | 47.11% |
| Dec 29, 2023 | 45.00M | 95.65% |
| Dec 30, 2022 | 23.00M | -93.90% |
| Dec 31, 2021 | 377.10M | -53.98% |
| Dec 31, 2020 | 819.50M | -45.64% |
| Dec 31, 2019 | 1.51B | 76.19% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivani Medical | 71.28M |
| Hyperfine | 71.17M |
| Zentek | 70.23M |
| Owlet | 68.51M |
| Prelude Therapeutics | 68.23M |
| Boundless Bio | 66.31M |
| HeartBeam | 66.14M |
| MAIA Biotechnology | 65.91M |